The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 14, 2020
Filed:
Aug. 28, 2013
Applicants:
Fundación Centro Nacional DE Investigaciones Cardiovasculares Carlos Iii (Cnic), Madrid, ES;
Hospital Clínic DE Barcelona, Barcelona, ES;
Inventors:
Borja Ibáñez Cabeza, Madrid, ES;
Ana García-Álvarez, Barcelona, ES;
Valentín Fuster Carulla, Madrid, ES;
Assignees:
FUNDACÍON CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (CNIC), Madrid, ES;
HOSPITAL CLÍNIC DE BARCELONA, Barcelona, ES;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/426 (2006.01); A61K 31/195 (2006.01); A61P 9/00 (2006.01); A61K 31/216 (2006.01); A61K 31/36 (2006.01); A61K 31/4412 (2006.01); A61K 31/55 (2006.01); A61K 31/5517 (2006.01); A61K 31/63 (2006.01);
U.S. Cl.
CPC ...
A61K 31/216 (2013.01); A61K 31/195 (2013.01); A61K 31/36 (2013.01); A61K 31/426 (2013.01); A61K 31/4412 (2013.01); A61K 31/55 (2013.01); A61K 31/5517 (2013.01); A61K 31/63 (2013.01);
Abstract
The invention relates to the use of selective agonists of beta-3 adrenergic receptors for the treatment and/or prevention of pulmonary hypertension.